EP2316921B1
(de)
*
|
2002-05-24 |
2014-05-14 |
Merck Sharp & Dohme Corp. |
Humaner neutraliserender Anti-IGFR Antikörper
|
CA2519113C
(en)
*
|
2003-04-02 |
2012-06-05 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
US7638605B2
(en)
|
2003-05-01 |
2009-12-29 |
ImClone, LLC |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
CN1835975B
(zh)
|
2003-08-13 |
2012-11-21 |
辉瑞产品公司 |
经修饰的人类igf-1r抗体
|
EP1694850B1
(de)
|
2003-11-12 |
2011-06-29 |
Schering Corporation |
Plasmidsystem zur expression mehrerer gene
|
AR046639A1
(es)
*
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
EP1740946B1
(de)
*
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Humane monoklonale antikörper gegen cd20
|
MX2007000610A
(es)
*
|
2004-07-16 |
2007-03-07 |
Pfizer Prod Inc |
Tratamiento de combinacion para enfermedades malignas no hematologicas usando un anti-cuerpo de receptor de factor i de crecimiento de tipo anti-insulina.
|
FR2873699B1
(fr)
*
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
EP2283831A3
(de)
*
|
2004-12-03 |
2013-10-23 |
Merck Sharp & Dohme Corp. |
Biomarker zur Vorauswahl von Patienten für die Anti-IGF1R-Therapie
|
MY146381A
(en)
*
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
GB0501741D0
(en)
*
|
2005-01-27 |
2005-03-02 |
Binding Site The Ltd |
Antibody
|
JP4875064B2
(ja)
*
|
2005-04-15 |
2012-02-15 |
シェーリング コーポレイション |
癌を処置または予防するための方法および組成物
|
JP2008546699A
(ja)
*
|
2005-06-15 |
2008-12-25 |
シェーリング コーポレイション |
抗igf1r抗体処方物
|
CA2612449A1
(en)
|
2005-06-17 |
2006-12-28 |
Imclone Systems Incorporated |
Receptor antagonists for treatment of metastatic bone cancer
|
FR2888850B1
(fr)
*
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
WO2007133822A1
(en)
*
|
2006-01-19 |
2007-11-22 |
Genzyme Corporation |
Gitr antibodies for the treatment of cancer
|
JP5198289B2
(ja)
|
2006-02-03 |
2013-05-15 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
前立腺癌の治療用アジュバントとしてのigf−irアンタゴニスト
|
CN101371140B
(zh)
|
2006-03-09 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
抗药物抗体的测定
|
BRPI0709843A2
(pt)
|
2006-03-28 |
2011-07-26 |
Biogen Idec Inc |
anticorpos de anti-igf-1r e usos dos mesmos
|
EP1998806A1
(de)
*
|
2006-03-28 |
2008-12-10 |
F. Hoffmann-Roche AG |
Formulierung eines anti-igf-1r humanen monoklonalen antikörpers
|
US7846724B2
(en)
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
US20080014203A1
(en)
*
|
2006-04-11 |
2008-01-17 |
Silke Hansen |
Antibodies against insulin-like growth factor I receptor and uses thereof
|
CA2655997A1
(en)
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Igfbp2 biomarker
|
EP2067044B1
(de)
|
2006-09-12 |
2013-07-03 |
F. Hoffmann-La Roche AG |
Assay für antikörper gegen arzneistoff
|
WO2008076278A2
(en)
|
2006-12-13 |
2008-06-26 |
Schering Corporation |
Methods of cancer treatment with igf1r inhibitors
|
WO2008098115A2
(en)
*
|
2007-02-07 |
2008-08-14 |
Xencor, Inc. |
Optimized igf-1r antibodies and methods of using the same
|
GB0702888D0
(en)
*
|
2007-02-14 |
2007-03-28 |
Glaxo Group Ltd |
Novel Antibodies
|
CN101617228A
(zh)
|
2007-02-27 |
2009-12-30 |
霍夫曼-拉罗奇有限公司 |
用于评估针对胰岛素样生长因子ⅰ受体的抗体的抑制活性的方法
|
US20100166747A1
(en)
*
|
2007-03-02 |
2010-07-01 |
Beltran Pedro J |
Methods and compositions for treating tumor diseases
|
WO2008144345A2
(en)
|
2007-05-17 |
2008-11-27 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
|
US20110097318A1
(en)
*
|
2007-08-31 |
2011-04-28 |
Amgen Inc. |
Solid-State Protein Formulation
|
US8383114B2
(en)
*
|
2007-09-27 |
2013-02-26 |
Amgen Inc. |
Pharmaceutical formulations
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
CN101896820A
(zh)
|
2007-12-15 |
2010-11-24 |
霍夫曼-拉罗奇有限公司 |
区分测定
|
WO2009079587A2
(en)
*
|
2007-12-18 |
2009-06-25 |
Schering Corporation |
Biomarkers for sensitivity to anti-igf1r therapy
|
JP5458020B2
(ja)
|
2007-12-21 |
2014-04-02 |
ロシュ グリクアート アクチェンゲゼルシャフト |
抗体の安定性試験
|
WO2010120599A2
(en)
|
2009-04-16 |
2010-10-21 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
US20100316639A1
(en)
|
2009-06-16 |
2010-12-16 |
Genentech, Inc. |
Biomarkers for igf-1r inhibitor therapy
|
ES2478294T5
(es)
|
2009-07-24 |
2024-08-02 |
Hoffmann La Roche |
Sistema de agitador
|
CN102656460B
(zh)
|
2009-10-19 |
2016-03-02 |
弗·哈夫曼-拉罗切有限公司 |
非交叉反应性抗IgG抗体
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
BR112012009828B8
(pt)
|
2009-10-26 |
2022-10-25 |
Hoffmann La Roche |
Método para a produção de uma imunoglobulina glicosilada e seu uso
|
WO2011053779A2
(en)
|
2009-10-30 |
2011-05-05 |
Bristol-Myers Squibb Company |
Methods for treating cancer in patients having igf-1r inhibitor resistance
|
WO2011083391A2
(en)
|
2010-01-05 |
2011-07-14 |
Pfizer Inc. |
Biomarkers for anti-igf-ir cancer therapy
|
TW201138821A
(en)
|
2010-03-26 |
2011-11-16 |
Roche Glycart Ag |
Bispecific antibodies
|
WO2011135040A1
(en)
|
2010-04-30 |
2011-11-03 |
F. Hoffmann-La Roche Ag |
Fluorescent antibody fusion protein, its production and use
|
SI2575935T2
(sl)
|
2010-06-07 |
2023-12-29 |
Amgen Inc. |
Naprava za dajanje zdravila
|
WO2011161119A1
(en)
|
2010-06-22 |
2011-12-29 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
WO2012022682A1
(en)
|
2010-08-17 |
2012-02-23 |
F. Hoffmann-La Roche Ag |
Anti-human igg1 antibody
|
CA2815282C
(en)
|
2010-11-05 |
2019-05-21 |
F. Hoffmann-La Roche Ag |
Optimized method for antibody capturing by mixed mode chromatography
|
JP2014510265A
(ja)
|
2011-02-02 |
2014-04-24 |
アムジェン インコーポレイテッド |
Igf−1rの阻害に関する方法および組成物
|
AU2012236573B2
(en)
|
2011-03-31 |
2016-06-02 |
Amgen Inc. |
Vial adapter and system
|
HUE042822T2
(hu)
|
2011-04-20 |
2019-07-29 |
Amgen Inc |
Automata befecskendezõ szerkezet
|
ES2667864T3
(es)
|
2011-06-22 |
2018-05-14 |
F. Hoffmann-La Roche Ag |
Eliminación de células diana mediante linfocitos T citotóxicos específicos de virus en circulación usando complejos que comprenden MHC de clase I
|
EP2766497A1
(de)
|
2011-10-13 |
2014-08-20 |
Bristol-Myers Squibb Company |
Verfahren zur auswahl und behandlung von krebs bei patienten mit igf-1r/ir-hemmern
|
IL301153B2
(en)
|
2011-10-14 |
2024-05-01 |
Amgen Inc |
Syringe and assembly method
|
WO2013071056A2
(en)
|
2011-11-11 |
2013-05-16 |
Duke University |
Combination drug therapy for the treatment of solid tumors
|
US8980259B2
(en)
|
2012-07-20 |
2015-03-17 |
Novartis Ag |
Combination therapy
|
EP2727941A1
(de)
|
2012-11-05 |
2014-05-07 |
MAB Discovery GmbH |
Verfahren zur Herstellung multispezifischer Antikörper
|
US20150259430A1
(en)
|
2012-11-05 |
2015-09-17 |
Mab Discovery Gmbh |
Method for the production of multispecific antibodies
|
CA3206182A1
(en)
|
2012-11-21 |
2014-05-30 |
Amgen Inc. |
Drug delivery device including insertion member and reservoir
|
MX361076B
(es)
|
2012-12-21 |
2018-11-27 |
Hoffmann La Roche |
Proteínas multifunción que comprenden complejo mayor de histocompatibilidad (cmh) de clase i multivalente unido mediante disulfuro.
|
EP2968775B1
(de)
|
2013-03-15 |
2019-12-18 |
Amgen Inc. |
Medikamentenkassette, autoinjektor und autoinjektorsystem
|
PL2970492T3
(pl)
|
2013-03-15 |
2019-10-31 |
Univ Wake Forest Health Sciences |
Przeciwciała przeciwko ludzkim i psim il-13ra2
|
IL292270B2
(en)
|
2013-03-22 |
2024-04-01 |
Amgen Inc |
Injector and assembly method
|
JP6563910B2
(ja)
|
2013-07-04 |
2019-08-21 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
|
MX2016005312A
(es)
|
2013-10-24 |
2016-08-11 |
Amgen Inc |
Inyector y metodo de montaje.
|
EP3501575B1
(de)
|
2013-10-24 |
2021-12-01 |
Amgen Inc. |
Arzneimittelabgabesystem mit temperaturempfindlicher steuerung
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
EP3785749A1
(de)
|
2014-05-07 |
2021-03-03 |
Amgen Inc. |
Autoinjektor mit stossabsorbierenden elementen
|
CN106470717B
(zh)
|
2014-06-03 |
2020-09-11 |
安姆根有限公司 |
药物递送系统和使用方法
|
WO2016033509A1
(en)
*
|
2014-08-29 |
2016-03-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Aquaporin-4 antibodies and uses thereof for the treatment of neuromyelitis optica
|
EP3943135A3
(de)
|
2014-10-14 |
2022-06-29 |
Amgen Inc. |
Arzneimittelinjektionsvorrichtung mit visuellen und hörbaren indikatoren
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
EP3848072A1
(de)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit näherungssensor
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
JP2018512184A
(ja)
|
2015-02-27 |
2018-05-17 |
アムジエン・インコーポレーテツド |
針ガードの移動に対する抵抗力の閾値が調整可能な針ガード機構を備えた薬物送達装置
|
CA2929542A1
(en)
*
|
2015-05-13 |
2016-11-13 |
Pfizer Inc. |
Treatment with anti-efna4 antibody-drug conjugates
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
US11200298B2
(en)
|
2016-03-15 |
2021-12-14 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
CA3018426A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
AU2018221351B2
(en)
|
2017-02-17 |
2023-02-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
EP3582825A1
(de)
|
2017-02-17 |
2019-12-25 |
Amgen Inc. |
Wirkstofffreisetzungsvorrichtung mit steriler fluidströmung und zugehöriges verfahren zur montage
|
JP2020508803A
(ja)
|
2017-03-06 |
2020-03-26 |
アムジエン・インコーポレーテツド |
作動防止特徴部を備える薬物送達デバイス
|
EP3592402A1
(de)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Nadeleinführung durch überdruck
|
AU2018230486B2
(en)
|
2017-03-09 |
2023-05-11 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
KR102517342B1
(ko)
|
2017-03-28 |
2023-03-31 |
암겐 인코포레이티드 |
플런저 로드 및 주사기 조립 시스템 및 방법
|
JP7200134B2
(ja)
|
2017-06-08 |
2023-01-06 |
アムジエン・インコーポレーテツド |
トルク駆動式薬物送達デバイス
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
EP3641857A1
(de)
|
2017-06-22 |
2020-04-29 |
Amgen Inc. |
Aufprall-/stossdämpfungsminderung bei geräteaktivierung
|
US11395880B2
(en)
|
2017-06-23 |
2022-07-26 |
Amgen Inc. |
Electronic drug delivery device
|
WO2019014014A1
(en)
|
2017-07-14 |
2019-01-17 |
Amgen Inc. |
NEEDLE INSERTION-RETRACTING SYSTEM HAVING DOUBLE TORSION SPRING SYSTEM
|
IL271173B2
(en)
|
2017-07-21 |
2024-04-01 |
Amgen Inc |
Gas permeable sealing element for drug container and methods of assembly
|
JP2020528296A
(ja)
|
2017-07-25 |
2020-09-24 |
アムジエン・インコーポレーテツド |
ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
|
EP3658206A1
(de)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit behälterzugangssystem und zugehörigem verfahren zur montage
|
WO2019032482A2
(en)
|
2017-08-09 |
2019-02-14 |
Amgen Inc. |
HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019046600A1
(en)
|
2017-08-30 |
2019-03-07 |
Amgen Inc. |
INSULIN-RELATED GROWTH FACTOR 1 RECEPTOR BINDING PROTEINS (IGF-1R) AND METHODS OF USE
|
US11759565B2
(en)
|
2017-10-04 |
2023-09-19 |
Amgen Inc. |
Flow adapter for drug delivery device
|
EP3691716B1
(de)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit verriegelungsvorrichtung und zugehöriges montageverfahren
|
EP3694578A1
(de)
|
2017-10-09 |
2020-08-19 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit antriebsanordnung sowie zugehöriges verfahren zur montage
|
EP3703779A1
(de)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
Systeme und ansätze zur sterilisation einer arzneimittelabgabevorrichtung
|
EP3706830B1
(de)
|
2017-11-06 |
2024-08-07 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit positionierungs- und durchflussmessung
|
EP3707075A1
(de)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Füllabschlussanordnungen und zugehörige verfahren
|
JP7247174B2
(ja)
|
2017-11-10 |
2023-03-28 |
アムジエン・インコーポレーテツド |
薬物送達デバイスのプランジャ
|
CA3079540A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
MA50903A
(fr)
|
2017-11-16 |
2021-05-12 |
Amgen Inc |
Auto-injecteur avec détection de décrochage et de point d'extrémité
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
EP3826699A1
(de)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Ausgabevorrichtung zur verabreichung von arzneimitteln
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
MA53320A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Ensemble de trajet de fluide pour dispositif d'administration de médicament
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
US12042642B2
(en)
|
2018-09-28 |
2024-07-23 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
TW202027806A
(zh)
|
2018-10-02 |
2020-08-01 |
美商安進公司 |
具有內部力傳遞的用於藥物遞送之注射系統
|
MX2021003491A
(es)
|
2018-10-05 |
2021-06-18 |
Amgen Inc |
Dispositivo de administracion de farmacos con indicador de dosis.
|
MX2021004219A
(es)
|
2018-10-15 |
2021-05-27 |
Amgen Inc |
Dispositivo de administracion de farmacos con mecanismo de amortiguacion.
|
CN112689523A
(zh)
|
2018-10-15 |
2021-04-20 |
安进公司 |
用于药物递送装置的平台组装方法
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
AU2019370159A1
(en)
|
2018-11-01 |
2021-04-22 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
US11213620B2
(en)
|
2018-11-01 |
2022-01-04 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
JP7510952B2
(ja)
|
2019-04-24 |
2024-07-04 |
アムジエン・インコーポレーテツド |
シリンジ滅菌確認アセンブリ及び方法
|
JP2022545227A
(ja)
|
2019-08-23 |
2022-10-26 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
CN113512116B
(zh)
|
2020-04-10 |
2022-09-20 |
苏州普乐康医药科技有限公司 |
一种抗igf-1r抗体及其应用
|
CN112794912B
(zh)
*
|
2021-04-14 |
2021-07-06 |
苏州普乐康医药科技有限公司 |
一种抗igf-1r抗体及其应用
|
WO2022246055A1
(en)
|
2021-05-21 |
2022-11-24 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
WO2023143484A1
(zh)
*
|
2022-01-29 |
2023-08-03 |
明慧医药(杭州)有限公司 |
一种抗原结合蛋白及其用途
|